CV Sciences, Inc. (OTCMKTS:CVSI – Get Free Report) was the recipient of a large growth in short interest during the month of October. As of October 15th, there was short interest totaling 36,668 shares, a growth of 158.4% from the September 30th total of 14,190 shares. Based on an average daily volume of 349,897 shares, the short-interest ratio is currently 0.1 days. Approximately 0.0% of the company’s shares are short sold.
CV Sciences Stock Down 5.9%
Shares of CV Sciences stock traded down $0.00 during trading hours on Friday, hitting $0.01. The company’s stock had a trading volume of 94,420 shares, compared to its average volume of 802,302. CV Sciences has a 12 month low of $0.01 and a 12 month high of $0.10. The stock has a 50 day moving average of $0.01 and a 200 day moving average of $0.03.
About CV Sciences
CV Sciences, Inc is a life sciences company focused on hemp-derived cannabidiol (CBD) and other plant-based wellness products. The company markets its consumer products under the PlusCBD brand, which is designed to provide consumers with a range of CBD formats for everyday wellness.
PlusCBD products have included CBD oil drops, softgels, gummies, capsules, topical creams and balms, and products intended for pets. The company has sold its products through e-commerce channels and retail distribution, primarily serving customers in the United States.
Founded in 2012, CV Sciences is headquartered in San Diego, California.
See Also
- Five stocks we like better than CV Sciences
- Amazon’s Record Margins Couldn’t Stop the Sell-Off—Here’s Why
- DoorDash’s $17 Billion Bet on Instacart Faces a Long Regulatory Road Ahead
- FTC Puts A Wrinkle In the Cintas and UniFirst Merger
- Breaching the Valuation: The Real Reason Fortinet Dropped
Receive News & Ratings for CV Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CV Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
